perio - step 3 Flashcards
SDCEP BPE 3
- assess extent of BoP
- assess modifiable risk factors i.e. smoking / suboptimal diabetes
- make preliminary perio diagnosis based on pt presentation
- at post tx review carry out full periodontal assessment inc 6PPC at involved sextants to determine if probing depths have reduced and to confirm perio diagnosis
SDCEP BPE 4
- full perio assessment inc 6PPC of whole dentition
- assess extent of BoP
- assess modifiable risk factors
how long after BSP step 2 do you do step 3
12 weeks
what is BSP step 3
management of non responding sites:
- reinforce OH / risk factor control / behaviour change
- moderate 4-5mm residual PPD reperform sub gingival PMPR
- deep residual pockets >6mm consider alternative causes
- consider referral for pocket mx / regenerative surgery
- if referral not possible reperform subgingival instrumentation
pt factors to consider prior to surgery
- OH <20% plaque & <10% bleeding
- quality of maintenance available & pt access to it
- ability of pt to tolerate procedure
- likely pt compliance to maintenance post surgery
- cost & pt acceptance
- aesthetics of site & potential for post op recession
tooth factors to consider prior to surgery
- access to non responding sites
- shape of defect
- pros / endo considerations
- tooth position / anatomy (tilting, overeruption, proximity to adjacent roots, enamel pearls, ridges / root grooves)
systemic / medical factors to consider prior to surgery
- smoking
- unstable angina / uncontrolled hypertension / stroke or MI within 6mths prior
- poorly controlled diabetes
- immunosuppressed pts
- anticoags
all must be controlled prior to surgery
options inc in step 3 (4)
- repeated subgingival instrumentation
- access flap surgery
- resective flap surgery
- regenerative flap surgery
local antimicrobials
e.g. CHX
locally delivered ABs
adjuncts to PMPR
may be indicated in unresponsive sites where surgery is contraindicated / not desired
BSP / SDCEP say not for routine care
egs of local antimicrobials
periochip - biodegradable gelatin matrix (2.5mg CHX) insert into pocket, slow release over 7 day period
dentomycin gel - 2% minocycline gel, 3-4 applications every 12 days
systemic antibiotics
antibiotic stewardship
BSP / SDCEP does NOT recommend routine use of systemic antibiotics as an adjunct to PMPR
consent process
- reason for providing surgical tx
- other options for managing area inc no tx
- consequences of no surgery
- nature of surgical procedure
- post op consequences i.e. the usual plus sensitivity, failure, mobility, non vitality, recession
- requirement for ongoing post op maintenance
- cost
aims of access surgery / open flap debridement
- access to areas of continued inflammation / infection
- usually for PPD >6mm
- to allow access for surgical debridement
why will pocket depth decrease
- increase in clinical attachment resulting from
- formation of long junctional epithelium
- increase in tissue tone which produces resistance to probing - decreased oedema leading to gingival recession
aim follow access surgery
- healing by repair
- long epithelial reattachment to root surface
what and why for regenerative perio surgery
tissue regeneration inc bone & functional PDL formation
indicated when
- intrabony defects >3mm or deeper as assessed radiographically (note this is not PD)
- class II or class III furcation defect
guided tissue regeneration (GTR)
barrier membranes +/- addition of bone derived grafts
membrane prevents gingival epithelium / CT from entering bone defect & to induce osteogenesis & pdl regeneration
creates space to acts as scaffold for vascularisation and cell ingrowth from base of defect
emdogain (enamel matrix derivative)
tissue healing agent derived from porcine tooth germ
forms matrix on root surface that mediates production of cementum by modulating wound healing process
induce regeneration of functional attachment